Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: Long-term follow-up of RTOG 92-04

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 3, 2002, Pages 548-557

  Komaki, R ^a   Seiferheld, W ^b   Ettinger, D ^c   Lee, J S ^a   Movsas, B ^d   Sause, W ^e  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d FOX CHASE CANCER CENTER   (United States)

^e Latter Day Saints Hospital   (United States)

Author keywords

Chemotherapy; Clinical trial; Lung cancer; Radiation therapy

Indexed keywords

CHEMOTHERAPY; PULMONARY DISEASES; RADIOTHERAPY; TOXICITY; TUMORS;

LUNG CANCER;

ONCOLOGY;

CISPLATIN; ETOPOSIDE; VINBLASTINE;

ADULT; ADVANCED CANCER; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; ESOPHAGITIS; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TREATMENT OUTCOME; WEIGHT REDUCTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIATION INJURIES; VINBLASTINE;

EID: 0036644245     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02793-1     Document Type: Article

References (26)

1. Role of radiotherapy in combined modality treatment of locally advanced nonsmall cell lung cancer
2. Improved survival in stage III non-small cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial
3. Radiation Therapy Oncology Group 88-08 and Eastern Cooperative Oncology Group 4588: Preliminary results of a phase III trial in regionally advanced, unresectable nonsmall cell lung cancer
4. Primary tumor control after radiotherapy for carcinoma of the bronchus
5. Effect of chemotherapy on locally advanced nonsmall cell lung carcinoma: A randomized study of 353 patients - GETCB, FNCLCC, and the CEBI trialists
6. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer
7. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group Protocol 91-06
8. Phase II trial of combination chemotherapy and irradiation in nonsmall cell lung cancer: Radiation Therapy Oncology Group 88-04
9. Toxicity criteria of the Radiation Therapy Oncology Group and the European Organization for Research and Treatment of Cancer
10. LE/II trials of fractionation in radiation therapy for cancer
11. One-sample multiple testing procedure for phase II clinical trials
12. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy: Report by the Radiation Oncology Group
13. Nonparametric estimation from incomplete observations
14. Regression models and life-tables
15. Design and analysis of randomised clinical trials requiring prolonged observation of each patient
16. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable nonsmall cell lung cancer: First analysis of a randomized trial in 353 patients
17. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable nonsmall cell lung carcinoma
18. Concurrent chemoradiation for stage III nonsmall cell lung cancer: From cisplatin alone to cisplatin + etoposide
19. Phase III comparison of sequential vs. concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer (NSCLC): Initial report of Radiation Therapy Oncology Group (RTOG) 9410
20. Sequential vs. concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): Analysis of failures in a phase III study (RTOG 9410)
21. Phase III study of concurrent vs. sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer
22. The hazard of accelerated tumor clonogen repopulation during radiotherapy
23. Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: Preliminary results
24. Gemcitabine (G) with concurrent chest radiation (XRT) followed by consolidation chemotherapy with gemcitabine plus cisplatin (CDDP): A phase I trial for patients with stage III non-small cell lung cancer (NSCLC)